CD4 and cancer: VIRMA (Figure 6E) was significantly associated with Cancer associated fibroblast (r = 0.285, p = 1.05e–04), Myeloid dendritic cell (r = 0.209, p = 4.92e–03), CD4+ T cell (r = 0.233, p = 1.61e–03), Neutrophil (r = 0.192, p = 9.91e–03).